These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
72 related items for PubMed ID: 8862411
1. Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family. Kienzle N, Young D, Silins SL, Sculley TB. Virology; 1996 Oct 01; 224(1):167-74. PubMed ID: 8862411 [Abstract] [Full Text] [Related]
2. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR. J Cell Physiol; 1993 Mar 01; 154(3):486-95. PubMed ID: 8382208 [Abstract] [Full Text] [Related]
3. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication. Van Scoy S, Watakabe I, Krainer AR, Hearing J. Virology; 2000 Sep 15; 275(1):145-57. PubMed ID: 11017796 [Abstract] [Full Text] [Related]
4. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines. Sinclair AJ, Jacquemin MG, Brooks L, Shanahan F, Brimmell M, Rowe M, Farrell PJ. Virology; 1994 Mar 15; 199(2):339-53. PubMed ID: 8122366 [Abstract] [Full Text] [Related]
5. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes. McClain K, Estrov Z, Raju U, Kelley PK, Aggarwal BB. Methods; 1997 Jan 15; 11(1):83-7. PubMed ID: 8990093 [Abstract] [Full Text] [Related]
6. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines. Zhang RD, Guan M, Park Y, Tawadros R, Yang JY, Gold B, Wu B, Henderson EE. AIDS Res Hum Retroviruses; 1997 Jan 20; 13(2):161-71. PubMed ID: 9007201 [Abstract] [Full Text] [Related]
7. Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1. Sugawara Y, Makuuchi M, Kato N, Shimotohno K, Takada K. EMBO J; 1999 Oct 15; 18(20):5755-60. PubMed ID: 10523318 [Abstract] [Full Text] [Related]
8. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W. J Med Virol; 2001 Sep 15; 65(1):114-20. PubMed ID: 11505452 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S, Takada K. EMBO J; 2000 Dec 15; 19(24):6742-50. PubMed ID: 11118209 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies. Cabras G, Decaussin G, Zeng Y, Djennaoui D, Melouli H, Broully P, Bouguermouh AM, Ooka T. J Clin Virol; 2005 Sep 15; 34(1):26-34. PubMed ID: 16087121 [Abstract] [Full Text] [Related]
11. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K. J Med Virol; 2003 Jul 15; 70(3):410-9. PubMed ID: 12767005 [Abstract] [Full Text] [Related]
12. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. Sheu LF, Chen A, Meng CL, Ho KC, Lee WH, Leu FJ, Chao CF. J Pathol; 1996 Nov 15; 180(3):243-8. PubMed ID: 8958799 [Abstract] [Full Text] [Related]
13. Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression and not in immunoblastic transformation. Yang L, Ikeda H, Lai Y, Yoshiki T, Takada K. J Med Virol; 2003 May 15; 70(1):126-30. PubMed ID: 12629653 [Abstract] [Full Text] [Related]
14. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2. Burgstahler R, Kempkes B, Steube K, Lipp M. Biochem Biophys Res Commun; 1995 Oct 13; 215(2):737-43. PubMed ID: 7488016 [Abstract] [Full Text] [Related]
15. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells. Hu LF, Chen F, Altiok E, Winberg G, Klein G, Ernberg I. Gan To Kagaku Ryoho; 2000 May 13; 27 Suppl 2():248-60. PubMed ID: 10895161 [Abstract] [Full Text] [Related]
16. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells. Cuomo L, Trivedi P, de Grazia U, Calogero A, D'Onofrio M, Yang W, Frati L, Faggioni A, Rymo L, Ragona G. J Med Virol; 1998 Jul 13; 55(3):219-26. PubMed ID: 9624610 [Abstract] [Full Text] [Related]
17. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Pokrovskaja K, Ehlin-Henriksson B, Bartkova J, Bartek J, Scuderi R, Szekely L, Wiman KG, Klein G. Cell Growth Differ; 1996 Dec 13; 7(12):1723-32. PubMed ID: 8959341 [Abstract] [Full Text] [Related]
18. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Callahan J, Pai S, Cotter M, Robertson ES. Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337 [Abstract] [Full Text] [Related]
19. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP. Krauer KG, Belzer DK, Liaskou D, Buck M, Cross S, Honjo T, Sculley T. Virology; 1998 Dec 20; 252(2):418-30. PubMed ID: 9878621 [Abstract] [Full Text] [Related]
20. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells. Staege MS, Lee SP, Frisan T, Mautner J, Scholz S, Pajic A, Rickinson AB, Masucci MG, Polack A, Bornkamm GW. Proc Natl Acad Sci U S A; 2002 Apr 02; 99(7):4550-5. PubMed ID: 11917131 [Abstract] [Full Text] [Related] Page: [Next] [New Search]